Reminder of Required Letter of Support for PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)"

Notice Number: NOT-GM-18-046

Key Dates
Release Date: August 10, 2018

Related Announcements
PAR-17-190

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to remind applicants of the requirement for a letter of support from the institution's Authorized Organizational Representative (AOR) for submission of an application to PAR-17-090 "Maximizing Investigators' Research Award for Early Stage Investigators (R35).

Part 2. Section IV.2. PHS 398 Research Plan

Note that a letter of support is required from the institution's Authorized Organizational Representative (AOR) indicating acceptance of the conditions of the MIRA as defined in the instructions for the Letter of Support attachment on the PHS 398 Research Plan form. PD/PIs are encouraged to work with their AOR to make sure this letter is included in this section of the application. Applications that omit this letter, or that do not indicate their acceptance of the conditions of an award, will be withdrawn without review.

We encourage all applicants to view the assembled application image in eRA commons prior to the due date and verify that the application includes this required letter. 

Inquiries

Please direct all inquiries to:

Kristine Willis, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-0943
Email: kristine.willis@mail.nih.gov